Scherle Peggy

CIK 00018246321 companyWILMINGTON, DE

SEC Profile

Transactions

Companies

Filings

CIK

0001824632

Recent Transactions

39 trades

Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2026-02-04+230,000→ 230,000 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2025-02-04+175,000→ 175,000 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2024-03-01+150,000→ 150,000 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2023-02-07+135,000→ 135,000 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2022-02-15+100,000→ 100,000 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-27$35.32/sh−2,700→ 176,234 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-27$1.43/sh+6,014→ 178,934 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-27$36.23/sh−2,707→ 173,527 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2021-08-27−6,014→ 27,018 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-27$37.08/sh−607→ 172,920 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2021-08-26−1,700→ 33,032 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-26$1.43/sh+1,700→ 174,620 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-26$35.19/sh−1,700→ 172,920 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-13$35.07/sh−2,286→ 172,920 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2021-08-13−1,728→ 34,732 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2021-08-13−558→ 42,672 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-13$1.89/sh+558→ 173,478 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-13$1.43/sh+1,728→ 175,206 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2021-07-27−20,000→ 36,460 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-07-27$1.43/sh+20,000→ 192,920 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-07-27$36.09/sh−680→ 172,920 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-07-27$35.45/sh−19,320→ 173,600 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2021-07-20+95,000→ 95,000 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-05-07$41.14/sh−5,836→ 173,120 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-05-07$41.85/sh−200→ 172,920 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2021-05-07−10,000→ 56,460 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-05-07$1.43/sh+10,000→ 182,920 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-05-07$40.30/sh−3,964→ 178,956 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-08$38.97/sh−669→ 174,589 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2021-04-08−4,630→ 66,460 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-08$39.57/sh−1,669→ 172,920 total
Award
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-08$1.43/sh+4,630→ 177,550 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-08$36.97/sh−1,417→ 176,133 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-08$37.72/sh−875→ 175,258 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-07$40.30/sh−200→ 172,920 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-07$39.02/sh−8,289→ 180,001 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-07$39.63/sh−6,881→ 173,120 total
Award
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-07$1.43/sh+15,370→ 188,290 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2021-04-07−15,370→ 71,090 total

Companies

Prelude Therapeutics Inc
Chief Scientific Officer
$PRLD

Recent Filings

Address

C/O PRELUDE THERAPEUTICS INCORPORATED 175 INNOVATION BOULEVARD

WILMINGTON, DE, 19805

View on SEC.gov